Close
Nordic 9Nordic 9

Oncode Oncology Bridge Fund (investor - Venture Capital)

Netherlands oncodeinstitute.nl
See something wrong or missing? Let us know
Offices:Utrecht
Average round investment:12.68M USD
Average number per year:1.5
Distribution: 2025 (2)2024 (1)
Portfolio companies: Netherlands CyclomicsNetherlands Laigo BioNetherlands Flindr Therapeutics
Mostly invests in: Netherlands Netherlands (3) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Oncode Oncology Bridge Fund

Name Criteria
Netherlands Carduso Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Dolby Family Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Netherlands Demcon
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Chris Gibson
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Flanders Future Techfund (FFTF)
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States SeaX Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Velar Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands dsm-firmenich Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Thuja Capital Management B.V.
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
France IXO Private Equity
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Top